Revisiting signatures of neutral tumor evolution in the light of complexity of cancer genomic data.
作者信息
Balaparya Abdul, De Subhajyoti
机构信息
Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
出版信息
Nat Genet. 2018 Dec;50(12):1626-1628. doi: 10.1038/s41588-018-0219-4.
Abstract
摘要
相似文献
1
Revisiting signatures of neutral tumor evolution in the light of complexity of cancer genomic data.
Nat Genet. 2018 Dec;50(12):1626-1628. doi: 10.1038/s41588-018-0219-4.
2
Reply to 'Revisiting signatures of neutral tumor evolution in the light of complexity of cancer genomic data'.
Nat Genet. 2018 Dec;50(12):1628-1630. doi: 10.1038/s41588-018-0210-0.
3
Neutral and adaptive genomic signatures of rapid poleward range expansion.
Mol Ecol. 2015 Dec;24(24):6163-76. doi: 10.1111/mec.13462.
4
[Statistical methods of comparative genomic analysis based on diffusion processes].
Biofizika. 2013 Mar-Apr;58(2):203-9.
5
Foundational errors in the Neutral and Nearly-Neutral theories of evolution in relation to the Synthetic Theory: is a new evolutionary paradigm necessary?
Biol Res. 2013;46(2):101-19. doi: 10.4067/S0716-97602013000200001.
6
Tumor evolution: Linear, branching, neutral or punctuated?
Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):151-161. doi: 10.1016/j.bbcan.2017.01.003. Epub 2017 Jan 19.
7
Multivariate analysis of genomic variables, effective population size, and mutation rate.
BMC Res Notes. 2019 Jan 25;12(1):60. doi: 10.1186/s13104-019-4097-3.
8
Constructive Neutral Evolution 20 Years Later.
J Mol Evol. 2021 Apr;89(3):172-182. doi: 10.1007/s00239-021-09996-y. Epub 2021 Feb 19.
9
Comparative genomics and the study of evolution by natural selection.
Mol Ecol. 2008 Nov;17(21):4586-96. doi: 10.1111/j.1365-294X.2008.03954.x.
10
Single Cell Genomics for Tumor Heterogeneity.
Adv Exp Med Biol. 2021;1187:205-214. doi: 10.1007/978-981-32-9620-6_10.
引用本文的文献
1
Time-resolved, integrated analysis of clonally evolving genomes.
PLoS Genet. 2023 Dec 14;19(12):e1011085. doi: 10.1371/journal.pgen.1011085. eCollection 2023 Dec.
2
Single-cell phylogenies reveal changes in the evolutionary rate within cancer and healthy tissues.
Cell Genom. 2023 Aug 17;3(9):100380. doi: 10.1016/j.xgen.2023.100380. eCollection 2023 Sep 13.
3
Artificial intelligence vs. evolving super-complex tumor intelligence: critical viewpoints.
Front Artif Intell. 2023 Jul 24;6:1220744. doi: 10.3389/frai.2023.1220744. eCollection 2023.
4
Gattaca: Base-Pair Resolution Mutation Tracking for Somatic Evolution Studies using Agent-based Models.
Mol Biol Evol. 2022 Apr 11;39(4). doi: 10.1093/molbev/msac058.
5
Clonal Evolution of Multiple Myeloma-Clinical and Diagnostic Implications.
Diagnostics (Basel). 2021 Aug 25;11(9):1534. doi: 10.3390/diagnostics11091534.
6
Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution.
Cancers (Basel). 2021 Mar 18;13(6):1380. doi: 10.3390/cancers13061380.
7
Signatures of neutral evolution in exponentially growing tumors: A theoretical perspective.
PLoS Comput Biol. 2021 Feb 11;17(2):e1008701. doi: 10.1371/journal.pcbi.1008701. eCollection 2021 Feb.
8
An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics.
Blood Cancer J. 2020 Oct 14;10(10):101. doi: 10.1038/s41408-020-00367-2.
9
Neutral syndrome.
Nat Hum Behav. 2020 Aug;4(8):780-790. doi: 10.1038/s41562-020-0844-7. Epub 2020 May 11.
10
Somatic substitution signature as an innovative tool in lung cancer diagnosis.
Sci Rep. 2019 Oct 10;9(1):14561. doi: 10.1038/s41598-019-51155-3.
Zotero 插件